Seaport Therapeutics ("Seaport" or the "Company"), a clinical-stage therapeutics company advancing novel neuropsychiatric medicines with a proven strategy and team, today announced the award of an up ...
ARPA-H award supports the development of an oral prodrug using Seaport’s proprietary Glyph™ platform to address dysfunctional ...
ARPA-H award supports the development of an oral prodrug, based on the Glyph™ platform initially developed at the Monash ...
The project is being led by the Monash Institute of Pharmaceutical Sciences (MIPS) in partnership with long term collaborator, Seaport Therapeutics, and is being backed by up to AUD$21.5M via the ARPA ...
As L.C. Clark, the former chief of the district’s campus police, put it: The children of Wilkinson County haven’t yet had the ...
Vasomune Therapeutics, Inc., ("Vasomune"), a clinical-stage biopharmaceutical company, today announced U.S. Food and Drug Administration (FDA) clearance of the Investigational New Drug (IND) ...
14hon MSN
Intimacy DOESN'T diminish with age - as sexy seniors prioritise a 'physical connection', study finds
You might think sexuality declines with age - but senior singletons want to get caught up in the throes of passion too, ...
Polycystic ovary syndrome (PCOS) represents one of the most prevalent chronic endocrine-metabolic disorders affecting women ...
Thirty years after its discovery, scientists are eyeing leptin with renewed interest, for everything from weight loss drug ...
There is a process to a patient being diagnosed with a rare condition and then collaborating with their physician, if they ...
Obesity research has become increasingly relevant as global rates of overweight and obesity continue to rise, affecting all age groups and communities.
The lead drug candidate, ALN1003, showed dose-related body weight loss and favorable body composition changes in the DIO mouse modelALN1003 also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results